InvestorsHub on MSN

HCW Biologics highlights positive findings for CAR-T therapy manufacturing

HCW Biologics Inc. (NASDAQ:HCWB) announced new research published in Science Advances indicating that its compound HCW9206 may improve the production of CAR-T cell therapies. The study was carried out ...
Business Wire

iCell Gene Therapeutics Presents First-in-Human Data of CLL1-CD33 Compound CAR T in Refractory Acute Myeloid Leukemia

NEW YORK--(BUSINESS WIRE)--iCell Gene Therapeutics, LLC announced results from a study ongoing at Chengdu Military General Hospital of ICG144, the first CLL1-CD33 Compound CAR T-cell (cCAR) in ...
Healio

Investigational compound shows ‘very dramatic’ capability to enhance CAR T-cell efficacy

Please provide your email address to receive an email when new articles are posted on . Researchers have developed a genetically modified form of the immune-stimulating protein interleukin-7 that ...